Han B - Search Results

1

Management of anlotinib-related adverse events in patients with advanced non-small cell lung cancer: Experiences in ALTER-0303.

Si X, Zhang L, Wang H, Zhang X, Wang M, Han B, Li K, Wang Q, Shi J, Wang Z, Cheng Y, Shi Y, Chen W, Wang X, Luo Y, Nan K, Jin F. Si X, et al. Among authors: han b. Thorac Cancer. 2019 Mar;10(3):551-556. doi: 10.1111/1759-7714.12977. Epub 2019 Jan 21. Thorac Cancer. 2019. PMID: 30666799 Free PMC article. Clinical Trial.

2

[Implication of micrometastatic cancer cells in the peripheral blood on prognosis of non-small cell lung cancer].

Huang JS, Dong QG, Bao GL, Han BH. Huang JS, et al. Zhonghua Zhong Liu Za Zhi. 2004 May;26(5):294-6. Zhonghua Zhong Liu Za Zhi. 2004. PMID: 15312367 Chinese.

3

[Randomized study of thalidomide combined with vinorelbine and cisplatin chemotherapy for the treatment of advanced non-small cell lung cancer].

Gu AQ, Han BH, Zhang XY, Shen J, Qi DJ, Xiong LW, Xin Y, Song YY. Gu AQ, et al. Zhonghua Zhong Liu Za Zhi. 2009 Apr;31(4):298-301. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 19615288 Clinical Trial. Chinese.

4

[Clinical observation of gefitinib for the treatment of 125 cases with advanced non-small cell lung cancer].

Gu AQ, Wang HM, Shi CL, Xiong LW, Gao ZQ, Han BH. Gu AQ, et al. Zhonghua Zhong Liu Za Zhi. 2010 Jan;32(1):71-4. Zhonghua Zhong Liu Za Zhi. 2010. PMID: 20211075 Clinical Trial. Chinese.

5

[Effects of a protein kinase C inhibitor combined with cisplatin on non-small cell lung cancer].

Gao ZQ, Han BH, Sha HF, Shi ZY, Yang XH, Feng JX. Gao ZQ, et al. Zhonghua Jie He He Hu Xi Za Zhi. 2010 Apr;33(4):284-8. Zhonghua Jie He He Hu Xi Za Zhi. 2010. PMID: 20646461 Chinese.

6

[The Analysis of Erlotinib on Brain Metastases in Patients with Non-small-cell Lung Cancer.].

Bai H, Han B. Bai H, et al. Among authors: han b. Zhongguo Fei Ai Za Zhi. 2009 Dec 20;12(12):1271-5. doi: 10.3779/j.issn.1009-3419.2009.12.09. Zhongguo Fei Ai Za Zhi. 2009. PMID: 20723382 Free article. Chinese.

7

Association of ABCC2 polymorphisms with platinum-based chemotherapy response and severe toxicity in non-small cell lung cancer patients.

Han B, Gao G, Wu W, Gao Z, Zhao X, Li L, Qiao R, Chen H, Wei Q, Wu J, Lu D. Han B, et al. Lung Cancer. 2011 May;72(2):238-43. doi: 10.1016/j.lungcan.2010.09.001. Epub 2010 Oct 12. Lung Cancer. 2011. PMID: 20943283

8

The value of tumor markers in evaluating chemotherapy response and prognosis in Chinese patients with advanced non-small cell lung cancer.

Jin B, Huang AM, Zhong RB, Han BH. Jin B, et al. Among authors: han bh. Chemotherapy. 2010;56(6):417-23. doi: 10.1159/000317580. Epub 2010 Nov 16. Chemotherapy. 2010. PMID: 21079400

9

[The clinical analysis of paclitaxel at two dose levels plus carboplatin as the first-line treatment in advanced non-small cell lung cancer].

Qian J, Shen J, Bai H, Han B. Qian J, et al. Among authors: han b. Zhongguo Fei Ai Za Zhi. 2011 Apr;14(4):323-8. doi: 10.3779/j.issn.1009-3419.2011.04.04. Zhongguo Fei Ai Za Zhi. 2011. PMID: 21496430 Free PMC article. Clinical Trial. Chinese.

10

[Relations between RRM1 protein expression levels and effects of gemcitabine and cisplatin chemotherapy in advanced non-small cell lung cancer patients].

Gao Z, Han B, Shen J, Gu A, Zhong H. Gao Z, et al. Among authors: han b. Zhongguo Fei Ai Za Zhi. 2011 Apr;14(4):340-4. doi: 10.3779/j.issn.1009-3419.2011.04.07. Zhongguo Fei Ai Za Zhi. 2011. PMID: 21496433 Free PMC article. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,839 results

Search Page

Filters